<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MolChord: Structure-Sequence Alignment for Protein-Guided Drug Design - Health AI Hub</title>
    <meta name="description" content="MolChord is a novel deep learning framework for structure-based drug design (SBDD) that aligns protein and molecule structures with their sequential and textual">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>MolChord: Structure-Sequence Alignment for Protein-Guided Drug Design</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.27671v1" target="_blank">2510.27671v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Wei Zhang, Zekun Guo, Yingce Xia, Peiran Jin, Shufang Xie, Tao Qin, Xiang-Yang Li
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.27671v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.27671v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">MolChord is a novel deep learning framework for structure-based drug design (SBDD) that aligns protein and molecule structures with their sequential and textual representations to generate drugs with desired pharmacological properties. It integrates the NatureLM autoregressive model as a molecule generator and a diffusion-based structure encoder, refining the alignment process using Direct Preference Optimization (DPO) on a property-aware dataset. The approach achieves state-of-the-art performance on the CrossDocked2020 benchmark.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is fundamental to drug discovery, as it provides an advanced computational method for efficiently designing and identifying novel molecular ligands that can bind to specific target proteins, thereby accelerating the development of new therapeutic agents.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>AI for accelerating drug discovery and design, specifically for identifying and optimizing lead compounds based on protein targets (structure-based drug design).</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>MolChord addresses critical challenges in Structure-Based Drug Design (SBDD), particularly aligning diverse protein and molecular representations and guiding generated molecules towards specific pharmacological properties.</li>
                    
                    <li>It unifies protein structural representations with molecular representations, integrating their textual descriptions (e.g., FASTA for proteins, SMILES for molecules).</li>
                    
                    <li>The system leverages NatureLM, an autoregressive model capable of processing and generating text, small molecules, and proteins, acting as the primary molecule generator.</li>
                    
                    <li>A diffusion-based structure encoder is utilized to effectively process and align the structural representations of proteins.</li>
                    
                    <li>To guide molecule generation towards desired properties, MolChord curates a specialized property-aware dataset by incorporating preference data.</li>
                    
                    <li>The alignment process is further refined using Direct Preference Optimization (DPO), a technique that leverages the property-aware dataset to ensure generated molecules possess targeted characteristics.</li>
                    
                    <li>Experimental validation on the CrossDocked2020 dataset demonstrates that MolChord achieves state-of-the-art performance across key evaluation metrics, affirming its potential as a practical SBDD tool.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>MolChord integrates an autoregressive model, NatureLM, which unifies text, small molecules, and proteins, functioning as the molecule generator. It employs a diffusion-based structure encoder for processing protein structural data. The alignment of protein and molecule structures with their sequential/textual representations is refined using Direct Preference Optimization (DPO) on a specially curated property-aware dataset that incorporates preference data to guide molecule generation towards desired pharmacological characteristics.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The proposed MolChord approach achieved state-of-the-art performance on key evaluation metrics when benchmarked against the CrossDocked2020 dataset. This demonstrates its superior capability in aligning protein and molecule structures and generating molecules with desired pharmacological properties for drug design.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>MolChord has the potential to significantly accelerate the drug discovery pipeline by offering a more efficient and accurate computational tool for identifying and optimizing potential drug candidates. By precisely designing molecules for specific protein targets and desired properties, it could lead to faster development of novel therapies, potentially reducing the time and cost involved in bringing new drugs to market.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the MolChord model or its current experimental validation.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention specific future research directions. However, implied future work could involve expanding the model's application to a wider range of protein targets and drug properties, validating generated molecules through experimental biological assays, or integrating more complex multi-objective optimization strategies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Structural Biology</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Structure-based drug design</span>
                    
                    <span class="tag tag-keyword">Protein-ligand alignment</span>
                    
                    <span class="tag tag-keyword">Drug discovery</span>
                    
                    <span class="tag tag-keyword">Generative AI</span>
                    
                    <span class="tag tag-keyword">Deep learning</span>
                    
                    <span class="tag tag-keyword">NatureLM</span>
                    
                    <span class="tag tag-keyword">Direct Preference Optimization</span>
                    
                    <span class="tag tag-keyword">Medicinal chemistry</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Structure-based drug design (SBDD), which maps target proteins to candidate
molecular ligands, is a fundamental task in drug discovery. Effectively
aligning protein structural representations with molecular representations, and
ensuring alignment between generated drugs and their pharmacological
properties, remains a critical challenge. To address these challenges, we
propose MolChord, which integrates two key techniques: (1) to align protein and
molecule structures with their textual descriptions and sequential
representations (e.g., FASTA for proteins and SMILES for molecules), we
leverage NatureLM, an autoregressive model unifying text, small molecules, and
proteins, as the molecule generator, alongside a diffusion-based structure
encoder; and (2) to guide molecules toward desired properties, we curate a
property-aware dataset by integrating preference data and refine the alignment
process using Direct Preference Optimization (DPO). Experimental results on
CrossDocked2020 demonstrate that our approach achieves state-of-the-art
performance on key evaluation metrics, highlighting its potential as a
practical tool for SBDD.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>21 pages</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>